1[1]DeGraba TJ.Immunogenetic suspectibility of atherosclerotic stroke.Implications on current and future treatment of vasclular inflammation[J].Stroke,2004,35(suppl 1):2712-2719.
3[3]Vliegen I,Duijvestijn A,Grauls G,et al.Cytomegalovirus infection aggravates atherogencsis in apoE knockout mice by both local and systemic immune activation[J].Microbes Infect,2004,6:17-24.
4[4]Espinola-Klein C,Rupprecht HJ,Blankenberg S,et al.Impact of infectious burden on progression of carotid atherosclerosis[J].Stroke,2002,33:2581-2586.
5[5]Muller BT,Huber R,Henrich B,et al.Chlamydia pneumoniae,herpes simplex virus and cytomegalovirus in symptomatic and asymptomatic high-grade internal carotid artery stenosis.Does infection influence plaque stability?[J].Vasa,2005,34:163-169.
6[6]Binder CJ,Horkko S,Dewan A,et al.Pneumococcal vaccination decreases atherosclerotic lesion formation:molecular mimicry between Streptococcus pneumoniae and oxidized LDL[J].Nat Med,2003,9:736-743.
7[7]DeGraba TJ,Siren AL,Penix L,et al.Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque[J].Stroke,1998,29:1405-1410.
8[8]Li AC,Glass CK.The macrophage foam cell as a target for therapeutic intervention[J].Nat Med,2002,8:1235-1242.
9[9]Smith JD,Trogan E,Ginsberg M,et al.Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotcin E[J].Proc Natl Acad Sci (USA),1995,92:8264-8268.
10[10]Lutgens E,Faber B,Schapira K,et al.Gene profiling in atherosclerosis reveals a key role for small inducible cytokines:validation using a novel monoeyte chemoattractaot protein monoclonal antibody[J].Circulation,2005,111:3443-3452.
5Nakase T, Yazamaki T, Qura N, et al. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J Ncurol Sci, 2008, 271 (2): 104-109.
6Terao S, Yilmaz G, Stokes KY, et a l. Blood cellderived RANTES mediates cerebral mierovascular dysfunction, inflammation and tissue injury after fooal isehemia reperfusion. Stoke, 2008, 39(2) : 2560-2570.
7Bone RC, Balk RA, Cera FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest, 1992, 101(6) : 1644-1655.
8Dhar R, Michael N. The Burden of the Systemic Inflammatory Response Predicts Vasospasm and Outcome after Subaraehnoid Hemorrhage. Neurocritical Care, 2008, 8 ( 3 ) : 404-412.
9Cao CC,Ding XQ,Ou ZL,et al. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats[J]. Kidney Int,2004, 65 (3) : 834-845.
10Cao C,Lu S,Dong C,et al. Abnormal DNA-binding of transcription factors in minimal change nephrotic syn- drome[J]. Pediatr Nephrol, 2001,16(10) :790-795.
